BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17047198)

  • 41. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
    Asano TK; McLeod RS
    Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.
    Wang J; Carvajal-Carmona LG; Chu JH; Zauber AG; ; Kubo M; Matsuda K; Dunlop M; Houlston RS; Sieber O; Lipton L; Gibbs P; Martin NG; Montgomery GW; Young J; Baird PN; Ratain MJ; Nakamura Y; Weiss ST; Tomlinson I; Bertagnolli MM
    Clin Cancer Res; 2013 Dec; 19(23):6430-7. PubMed ID: 24084763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk.
    Tijhuis MJ; Wark PA; Aarts JM; Visker MH; Nagengast FM; Kok FJ; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2943-51. PubMed ID: 16365014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
    Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
    Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
    Asano TK; McLeod RS
    Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma.
    Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):704-12. PubMed ID: 15290664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.
    Murphy G; Sansbury LB; Cross AJ; Stolzenberg-Solomon R; Laiyemo A; Albert PS; Wang Z; Schatzkin A; Lehman T; Kalidindi A; Modali R; Lanza E
    Cancer Causes Control; 2008 Sep; 19(7):751-8. PubMed ID: 18322814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
    Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
    Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival.
    Zell JA; Ziogas A; Ignatenko N; Honda J; Qu N; Bobbs AS; Neuhausen SL; Gerner EW; Anton-Culver H
    Clin Cancer Res; 2009 Oct; 15(19):6208-16. PubMed ID: 19789310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma lipoxin A
    Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
    Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial.
    Baron JA; Cole BF; Mott L; Haile R; Grau M; Church TR; Beck GJ; Greenberg ER
    J Natl Cancer Inst; 2003 May; 95(10):717-22. PubMed ID: 12759389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.
    Hubner RA; Muir KR; Liu JF; Sellick GS; Logan RF; Grainge M; Armitage N; Chau I; Houlston RS
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1607-13. PubMed ID: 16985020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.
    Han SS; Sue LY; Berndt SI; Selhub J; Burdette LA; Rosenberg PS; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):417-27. PubMed ID: 22253295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma.
    Song Y; Manson JE; Lee IM; Cook NR; Paul L; Selhub J; Giovannucci E; Zhang SM
    J Natl Cancer Inst; 2012 Oct; 104(20):1562-75. PubMed ID: 23066166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
    Stern MC; Siegmund KD; Corral R; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study.
    van den Donk M; Buijsse B; van den Berg SW; Ocké MC; Harryvan JL; Nagengast FM; Kok FJ; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1562-6. PubMed ID: 15941973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
    Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence.
    Hubner RA; Muir KR; Liu JF; Logan RF; Grainge M; Armitage N; Shepherd V; Popat S; Houlston RS;
    Clin Cancer Res; 2006 Nov; 12(21):6585-9. PubMed ID: 17085674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.